Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM5Q2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,666
Award facts
- Contract value 100% obligated
- $12,666.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12,666.48 firm fixed-price delivery order on December 3, 2025, for the supply of Ocrevus 300 mg/10 mL vials. The contract is non-competitive with no set-aside designation and has an ultimate completion date of December 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs, from specialty medications to brand-name and generic drugs across multiple therapeutic domains. The delivery order will be performed at AmerisourceBergen's Conshohocken facility. The DLA Troop Support is currently planning to establish a Pharmaceutical Prime Vendor Global Program Generation V contract structure with multiple regional awards, potentially involving three or more contractors to support various government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FM5Q2?
SPE2DR26FM5Q2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FM5Q2 worth?
The government has obligated $12,666 on SPE2DR26FM5Q2.
Is contract SPE2DR26FM5Q2 an order under another contract?
Yes. SPE2DR26FM5Q2 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM5Q2 competed?
The extent of competition for SPE2DR26FM5Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award